Concomitant Gain of 1q21 and MYC Translocation Define a Poor Prognostic Subgroup of Hyperdiploid Multiple Myeloma

Haematologica - Italy
doi 10.3324/haematol.2015.136929
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Prognostic Value of Chromosome 1q21 Gain by Fluorescent in Situ Hybridization and Increase CKS1B Expression in Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

1q21 Gain Combined With High‐Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China

Oncologist
Cancer ResearchMedicineOncology
2019English

Hypodiploid Multiple Myeloma Is Characterized by More Aggressive Molecular Markers Than Non-Hyperdiploid Multiple Myeloma

Haematologica
Hematology
2013English

Low Serum miR-19a Expression as a Novel Poor Prognostic Indicator in Multiple Myeloma

International Journal of Cancer
Cancer ResearchOncology
2014English

The Hydroxymethylome of Multiple Myeloma Identifies FAM72D as a 1q21 Marker Linked to Proliferation

Haematologica
Hematology
2019English

IL6R-STAT3-ADAR1 (P150) Interplay Promotes Oncogenicity in 1q21(amp) Multiple Myeloma

Haematologica
Hematology
2019English

Prognostic Value of CD56 Expression in Multiple Myeloma

Research in Oncology
2020English

Characterisation and Prognostic Impact of Immunoparesis in Relapsed Multiple Myeloma

British Journal of Haematology
Hematology
2020English

Biclonal Origin Prevails in Concomitant Chronic Lymphocytic Leukemia and Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy